Medical & Health: Biotechnology News
|Receive press releases from this Industry Distribution Channel: By Email
PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. Anelixis... - November 20, 2019 - ALS Therapy Development Institute
Nuriv® releases patented CBD formulations: RELAX, SLEEP, JOINT, along with its stand-alone CBD products, Hazelnut, Chocolate Brownie and French Vanilla. These release a powerfull Micellized form of CBD in amazing flavors, such as Peanut Butter Cup and Chocolate Brownie. Micellized compounds that are water insoluble absorb quicker, half speedy onset and improved Pharmacokinetics. 20mg CBD per 10ml serving and 22 servings per 8oz. - November 20, 2019 - VIRUN
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
SMi Reports: the agenda and speaker overview of the upcoming SMi 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view. - November 07, 2019 - SMi Group
Academy Medical announces that their vendor partner, RenovoDerm has been added to their DoD DAPA contract. Through Academy Medical’s contract, RenovoDerm will market their Phoenix Wound Matrix and Rotium Bioresorbable Wick products to DoD medical facilities. - November 06, 2019 - Academy Medical
NuvOx Pharma, Inc, a clinical stage biopharmaceutical company developing NanO2TM emulsion for oxygen delivery today announced the issuance of US Patent 10,456,468 – Fractionated Radiotherapy and Chemotherapy with an Oxygen Therapeutic. NanO2TM emulsion is designed to increase tumor oxygen levels... - November 03, 2019 - NuvOx Pharma
Varicose Veins Doctors is a trusted vein treatment clinic in Manhattan, NY. The clinic has made a name for itself by offering exceptional patient care and a selection of effective treatment options for vein diseases. Their teams of experts use state-of-the-art equipment to perform complex procedures for pain relief. - October 25, 2019 - Varicose Veins Doctors
In a move that benefits life science companies throughout the San Diego area, Bench International has hired Tom Murphy as its new Vice President of Business Development and Executive Recruitment. Murphy, who led the business development program at CONNECT, a top innovation company accelerator in San... - October 24, 2019 - Bench International
Continuing the concussion discussion with Alicia Kali, CEO of Panacea Biomed and Purpose DRVN, and Ultimate Sports Networks' host Frank Gordon. - October 18, 2019 - Ultimate Sports Networks Unlimited, LLC.
Aciont was issued a U.S. patent that covers an important aspect of the novel design of its main Visulex ocular drug delivery system which has been tested for safety and efficacy in its lead clinical program under U.S. IND. - October 12, 2019 - Aciont Inc.
BÜHLMANN CALEX® Cap, a single use tube intended for the preparation of human stool samples to be used with the BÜHLMANN fCAL® turbo, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - September 25, 2019 - BUHLMANN Diagnostics Corp
The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company
In 2017, the Indian Government introduced a National Health Policy (Ayushman Bharat or Healthy India) that aims to offer universal health coverage and provide the foundation for equitable healthcare. In this paper, SKP examines the potential of the NHPS and attempts to study the impact it creates on healthcare accessibility along with opportunities created for various stakeholders in the industry. - September 22, 2019 - SKP Group
CloudLIMS releases a new training module continues commitment to supporting ISO 17025 ISO/IEC 17025 accreditation. - September 20, 2019 - CloudLIMS
Oncoheroes Biosciences Inc (“Oncoheroes”) and Boehringer Ingelheim International GmbH (“Boehringer Ingelheim”) have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered and developed by Boehringer... - September 19, 2019 - Oncoheroes Biosciences Inc.
Digital DNAtix Ltd., the Israeli cyber genetics startup, has announced the first free anonymous genetic vault service. DNAtix developed the Cyber Genetics Smart Platform for Digital Genetics. Lack of privacy is currently a barrier for so many people who want to have their DNA tested but are afraid to give their genetic data away. As of today anyone can anonymously upload their raw file from 23&Me and Ancestry.com onto the DNAtix platform. - September 17, 2019 - Digital DNAtix Ltd.
Dr. Marty Makary, Susan Dentzer and more are joining NRHI on October 15-16 to discuss critical issues impacting today’s healthcare landscape. - September 12, 2019 - Network for Regional Healthcare Improvement
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of expression... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
The city of San Diego has all the components to become a global R&D hub, and Bench International is announcing its footprint and commitment to make a direct impact by building the hub’s position on the global life science stage.
Effective Sept. 1, Bench International has become embedded in... - September 05, 2019 - Bench International
RapidBac™Vet is a 17-minute, in-house test for bacteria in urine. For use on both dogs and cats. RapidBac™Vet has been validated in clinical studies comparing RapidBac™Vet test results to gold-standard urine culture with >97% accuracy at one-third the cost of a urine culture. - August 29, 2019 - RapidBac™Vet
ABA Publishing has released a new book, "The Law of Artificial Intelligence and Smart Machines: Understanding AI and the Legal Impact," co-authored by attorney and industry expert, Eric Boughman from the law firm of ForsterBoughman. It examines the legal implications of artificial intelligence and discusses a wide-range of topics including healthcare regulation, data and privacy concerns, cybernetics and bio-robotics, copyright law, cybersecurity issues, and the practice of transactional law. - August 22, 2019 - ForsterBoughman
8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC
Latest accolade follows a year of 30% revenue growth and thought leadership. - August 09, 2019 - Arteric
Thrombolex, Inc. today announced the enrollment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir™ Endovascular Catheter for the treatment of submassive pulmonary embolism (PE). The device was designed to quickly and safely dissolve thrombus and restore... - July 29, 2019 - Thrombolex, Inc.
Lawsuit alleges self-dealing in Hedgepath Pharmaceuticals, Inc. by its controlling stockholder, an indirect subsidiary of Mayne Pharma Group Ltd. with estimated damages exceeding $800,000,000. - July 23, 2019 - Hedgepath LLC
Rubix LS will collaborate with the United Nations, Global Health Policy Advocates and many more on an opportunity to collect data geared with leaping toward prevention of infectious diseases. - July 20, 2019 - Rubix LS
Optima to host post-conference workshop at Lyophilization USA. - July 07, 2019 - SMi Group
Tigerlily Foundation is leading the charge to make an impact on MBC related concerns and young women of color, by hosting the first ever Metastatic Breast Cancer Disparities Listening Summit on March 20, 2019. This unique forum gave young women of color a platform that was different from the norm - they voiced their needs as the experts, while industry, healthcare and policymakers listened. - June 28, 2019 - Tigerlily Foundation
BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - June 27, 2019 - BUHLMANN Diagnostics Corp
Virtus Group, LLC announces its partnership with Betts Consulting. The resulting alliance offers 40 years of experience in Pre-Clinical, as well as Phases I-IV of Clinical Development Services. Adding expertise in the CMC, CMC Regulatory Affairs, Project Management, and Finished Products area. - June 27, 2019 - Virtus Group, LLC
BioSource Cultures & Flavors, a primary manufacturer of lactic cultures and flavors located in Muskego, Wisconsin, has recently been purchased in 100% equity by its President and Founder, Dr. Narayan Suresh. - June 25, 2019 - BioSource Cultures and Flavors
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result - June 23, 2019 - Arteric
Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. “Adding... - June 22, 2019 - Cayman Chemical Company
This past May over 1,100 members of Orangetheory Fitness ran, rowed, and lifted, earning “splat points,” which they turned into $4.5 million in donations for Augie’s Quest to Cure ALS. With this donation Augie’s Quest is supporting non-profit biotech, the ALS Therapy Development Institute (ALS TDI), to fast track cure-driven drugs for ALS. - June 20, 2019 - ALS Therapy Development Institute
CovalX has partnered with Shimadzu Scientific Instruments to offer the OMEGATOF, an integrated MALDI solution for ultra high-mass detection. With a focus on the detection of large molecules, including biotherapeutics, protein complexes, aggregates, and antibody-antigen interactions in a benchtop footprint... - June 13, 2019 - CovalX
Corey Dambacher, Ph.D. of La Jolla, California has been recognized as a Professional of the Year for 2019 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the field of biotechnology consulting.
About Corey Dambacher
With over 20 years experience,... - June 12, 2019 - Strathmore Worldwide
Designer Cannabinoids take center stage at Ingredient Alliance. - June 11, 2019 - Ingredient Alliance
Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards. - June 05, 2019 - Cayman Chemical Company
The Dallas based research company plans to roll out a new clinical rating training program, Pillar Precision. The program includes a clinician guide featuring best practices for specific CNS indications, placebo response training, malingering detection, data-driven decision making, and multi-site rating... - May 24, 2019 - Pillar Clinical Research
Apostle Inc. is pleased to announce the completion of its series A financing, raising $3.3 million. The investment round is led by ShangBay Capital, a Silicon Valley-based venture capital firm, focused on investing in early stage medical device and biotech companies. Three other Silicon Valley-based... - May 24, 2019 - Apostle Inc
Kantar today announced that it has entered into a strategic partnership with Komodo Health to develop new and creative solutions for linking clinical encounter and patient reported outcomes (PRO) data. The collaboration with Komodo Health will provide data-driven artificial intelligence (AI) tools to top life science companies to reduce the burden of disease and improve patient outcomes. - May 21, 2019 - Kantar
New Claritis(TM) Solution Links PRO and Clinical Data – Representing Major Advancement in Evidence Generation for Real World Research - May 20, 2019 - Kantar
With the increasing security concerns and rise in the deployment of biometric fingerprint, facial and iris recognition devices, several verticals are making a smart move by adopting biometric technology. - May 19, 2019 - Mantra Softech India Pvt. Ltd.
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), was proud to sponsor the entire staff of the ReproTech Nevada office who participated in Moms on the Run, a fitness organization that raises money to assist... - May 19, 2019 - ReproTech, Ltd.
On May 18th, first responders will unite for a tug-of-war event at Tanglewood to raise money for ALS research. - May 11, 2019 - ALS Therapy Development Institute
President and Chief Strategist Shares Two Case Studies That Illustrate How to Leverage Artificial Intelligence to Achieve Business Goals. - May 10, 2019 - Arteric
A full-service offering to accelerate immunotherapy discovery and development. - May 09, 2019 - ENPICOM BV
May is ALS Awareness Month. The ALS Therapy Development Institute is inviting the general public to participate, and hoping to inspire a larger dialogue around ALS, through #AskMeAboutALS. - May 01, 2019 - ALS Therapy Development Institute
CloudLIMS releases the Document module for its LIMS to facilitate testing laboratories meet ISO/IEC 17025 accreditation requirements. - April 20, 2019 - CloudLIMS
SMi Group is pleased to announce the next Biosimilars Conference, the first global event taking place at the Copthorne Tara Hotel in London, on 25th and 26th September 2019. - April 18, 2019 - SMi Group
|Press Releases 1 - 50 of 1,799
||Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next